Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients

Erenumab showed efficacy in migraine prevention, however we cannot identify which patients to treat by predicting efficacy response. The aim of this study was to compare changes in cerebral blood flow (CBF) reflected by transcranial Doppler (TCD) in erenumab good responders (GR) and non-responders,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowaczewska, Magdalena, Straburzyński, Marcin, Meder, Grzegorz, Kaźmierczak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201252/
https://www.ncbi.nlm.nih.gov/pubmed/34200202
http://dx.doi.org/10.3390/jcm10112523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201252/
https://www.ncbi.nlm.nih.gov/pubmed/34200202
http://dx.doi.org/10.3390/jcm10112523

Ejemplares similares